Academic Bibliography

Search 200 years of publications by Ghent University researchers.

Tijl Vermassen

Faculty of Medicine and Health Sciences > Department of Internal Medicine and Pediatrics

ORCID iD: 0000-0002-1335-9966

Add to list
DNA-methylation as diagnostic and prognostic biomarker for oropharyngeal cancer : a proof-of-concept study

Tijl Vermassen (UGent) , Hannelore Hamerlinck (UGent) , David Creytens (UGent) , Anouk Dhanyns, Elizaveta Padalko (UGent) , Sylvie Rottey (UGent) , Jens Debacker (UGent) , Michael Saerens (UGent) and Wouter Huvenne (UGent)

(2026) RADIOTHERAPY AND ONCOLOGY. In Radiotherapy and Oncology 216(Supplement 1). p.S26-S27
Add to list
- Journal Article
- A1
- open access
PET and SPECT imaging of macrophages in the tumor stroma : an update

Shaobo Li (UGent) , Alex Maes, Tijl Vermassen (UGent) , Justine Maes, Chabi Sathekge, Sylvie Rottey (UGent) and Christophe Van De Wiele (UGent)

(2025) JOURNAL OF CLINICAL MEDICINE. 14(14).
Add to list
- Journal Article
- A1
- open access
A comprehensive review of SSTR-based Spect and Pet imaging in chronic inflammatory and immune-mediated diseases

Shaobo Li (UGent) , Alex Maes, Tijl Vermassen (UGent) , Justine Maes, Sylvie Rottey (UGent) and Christophe Van De Wiele (UGent)

(2025) JOURNAL OF CLINICAL MEDICINE. 14(23).
Add to list
- Conference Paper
- C3
Exploring the landscape of academic research

Charlotte Bertrand, France Vrijens, Marielle Sautois, Sofie De Vos, Levi Hoste (UGent) and Tijl Vermassen (UGent)

(2025) Healixia Clinical Conference 2025, Abstracts.
Add to list
- Conference Paper
- C3
- open access
Fractionated versus single-dose PSMA-targeted radioligand therapy as adjuvant therapy in a murine model for oral squamous cell carcinoma treated with immune checkpoint inhibitors

Michaël Henrotte (UGent) , David Creytens (UGent) , Filip De Vos (UGent) , Benedicte Descamps (UGent) , Lindsey Devisscher (UGent) , Gabriële Holtappels (UGent) , Wouter Huvenne (UGent) , Ken Kersemans (UGent) , Amber Meskens (UGent) , Sara Neyt (UGent) , et al.

(2025) 38th Annual Congress of the European Association of Nuclear Medicine - Abstracts. In EANM Innovation 1. p.s238-s239
Add to list
- Conference Paper
- C3
- open access
Prostate-specific membrane antigen-targeted radionuclide therapy as adjunct to Immune checkpoint Inhibition in an immunocompetent murine model for oral squamous cell carcinoma

Michaël Henrotte (UGent) , David Creytens (UGent) , Filip De Vos (UGent) , Benedicte Descamps (UGent) , Lindsey Devisscher (UGent) , Wouter Huvenne (UGent) , Ken Kersemans (UGent) , Sara Neyt (UGent) , Sylvie Rottey (UGent) , Michael Saerens (UGent) , et al.

(2025) 11th European Congress on Head & Neck Oncology, Abstracts.
Add to list
- Journal Article
- A1
- open access
Prognostication of brain-metastasized patients receiving subsequent systemic therapy : a single-center long-term follow-up

Tijl Vermassen (UGent) , Charlotte Van Parijs, Stijn De Keukeleire (UGent) , Katrien Vandecasteele (UGent) and Sylvie Rottey (UGent)

(2025) CURRENT ONCOLOGY. 32(2).
Add to list
A comprehensive view of N-glycosylation as clinical biomarker in prostate cancer

Lissa Eggermont (UGent) , Nicolaas Lumen (UGent) , Charles Van Praet (UGent) , Joris Delanghe (UGent) , Sylvie Rottey (UGent) and Tijl Vermassen (UGent)

(2025) BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER. 1880(1).
Add to list
- Journal Article
- A1
- open access
The association between urine N-glycome and prognosis after initial therapy for primary prostate cancer

Tijl Vermassen (UGent) , Nicolaas Lumen (UGent) , Charles Van Praet (UGent) , Nico Callewaert (UGent) , Joris Delanghe (UGent) and Sylvie Rottey (UGent)

(2024) BIOMEDICINES. 12(5).
Add to list
- Journal Article
- A1
- open access
Comparison of different estimated glomerular filtration rates for monitoring of kidney function in oncology patients

Tijl Vermassen (UGent) , Karen Geboes (UGent) , Nicolaas Lumen (UGent) , Charles Van Praet (UGent) , Sylvie Rottey (UGent) and Joris Delanghe (UGent)

(2024) CLINICAL KIDNEY JOURNAL. 17(1).

1
2
3
4
…
6
7

Next →